These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31691294)

  • 1. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.
    Bach AC; Lo KS; Pathirana T; Glasziou PP; Barratt AL; Jones MA; Bell KJ
    Med J Aust; 2020 Jan; 212(1):17-22. PubMed ID: 31691294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
    Pathirana T; Hayen A; Doust J; Glasziou P; Bell K
    BMJ Open; 2019 Mar; 9(3):e022457. PubMed ID: 30858156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of increasing mortality with longer time to diagnosis of cancer: is there a paediatric exception?
    Brasme JF; Grill J; Gaspar N; Oberlin O; Valteau-Couanet D; Chalumeau M
    Eur J Cancer; 2014 Mar; 50(4):864-6. PubMed ID: 24388772
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
    Ferlay J; Steliarova-Foucher E; Lortet-Tieulent J; Rosso S; Coebergh JW; Comber H; Forman D; Bray F
    Eur J Cancer; 2013 Apr; 49(6):1374-403. PubMed ID: 23485231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of the four major cancers in South Dakota.
    Clarke J
    S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year relative survival from prostate, breast, colorectal and lung cancer.
    Ellison LF; Gibbons L;
    Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care.
    Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P
    Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the magnitude of cancer overdiagnosis in Australia.
    Glasziou PP; Jones MA; Pathirana T; Barratt AL; Bell KJ
    Med J Aust; 2020 Mar; 212(4):163-168. PubMed ID: 31858624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
    Wright CM; Nowak AK; Halkett G; Moorin RE
    BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of age in screening for cancer.
    Law MR; Morris JK; Wald NJ
    J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leading cancers--changes in five-year relative survival.
    Ellison LF; Gibbons L
    Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of cancer burden in Trentino-Alto Adige.
    Piffer S; Gentilini M; Rizzello R; Mazzoleni G; Bellù F; Rossi S
    Tumori; 2013; 99(3):296-307. PubMed ID: 24158058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
    O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
    Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in educational inequalities in mortality, seven types of cancers, Norway 1971-2002.
    Elstad JI; Torstensrud R; Lyngstad TH; Kravdal O
    Eur J Public Health; 2012 Dec; 22(6):771-6. PubMed ID: 22167478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of cancer burden in Sicily.
    Tumino R; Capocaccia R; Traina A; Madeddu A; Contrino ML; Zigon G
    Tumori; 2013; 99(3):399-407. PubMed ID: 24158070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer mortality surveillance--United States, 1990-2000.
    Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
    MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.